Heavy Industries Ministry receives proposal from K'taka Govt for 14028 e-buses (See 'Corp Brief') Pakistan PM Shehbaz Sharif makes overtures to India; urges for settlement of outstanding issues through peaceful means; Opposition agrees to support Centre’s diplomatic outreach to change perceptions of recent Indo-Pak conflict Department of Biotechnology, BIRAC host webinar on Biomanufacturing for mRNA Therapeutics (See 'Corp Brief') Mumbai Airport ropes in Indo Thai Airport Services for ground handling work following revocation of security clearance of Turkish ground handling firm Celebi IBCA - Need enhanced efforts for trans-boundary conservation of Himalayan fauna: Min (See 'Corp Brief') IDF commences new operation in Gaza strip; objectives include rescue of remaining Israeli hostages and ensuring comprehensive defeat of Hamas MoS inaugurates new ATC Tower at Kolhapur Airport (See 'Corp Brief') Govt entry for Pakistani goods entering India via third country Chouhan announces Rs 339 Cr aid for development of Agri sector in Nagaland (See 'Corp Brief') India to study sustainability of Human Life in Space: MoS (See 'Corp Brief') PMLA - Under PMLA reasons to believe should not only be with regard to possession of proceeds of crime but also about its likelihood to be concealed, transferred or dealt with: TRIBUNAL (See 'Legal Desk') 'Aatmnirbhar Bharat' in Quantum Tech: Indigenous approaches discussed at CSIR-NPL (See 'Corp Brief') DEPwD organizes 'Inclusive India Summit' (See 'Corp Brief') IBC - Case can be disposes of with direction to Mr. Surender Devasani to inform Board regarding results of ongoing investigation by RoC Bangalore: IBBI (See 'Legal Desk') India reaffirms commitment to Buddha's Timeless Teachings (See 'Corp Brief') Competition Act - If challenged differentiation rests on objective commercial justification, or if it is open on identical terms to every purchaser similarly placed, then price can't be stigmatised as abusive: SC (See 'Legal Desk') 'Inclusive India Summit' to be organized on Global Accessibility Awareness Day - 15th May 15 (See 'Corp Brief') IPR - Mere addition of suffixes would not make any significant difference to test of deceptive similarity: HC (See 'Legal Desk') MoS launches Voluntary Blood Donation Drive by DoPT (See 'Corp Brief') IBC - Date of default mentioned in Part IV of application u/s 7 of IBC can't be changed merely on basis that arbitral award was passed subsequent to filing of application: NCLAT (See 'Legal Desk') CCI approves demerger of MDO Business of Thriveni Earthmovers into Thriveni Earthmovers (See 'Corp Brief') CCI nod for acquisition of shareholding in EPL Limited by Indorama Netherlands (See 'Corp Brief') IBC - NCLAT, acting as Adjudicating Authority under Insolvency and Bankruptcy Code, has no power to condone delays in filing appeals beyond prescribed limit of 45 days u/s 61(2): SC (See 'Legal Desk') CCI okays combination by AIPCF VIII A-TE Funding L.P. in Perseus Parent L.P (See 'Corp Brief') A&C - Mere signing of discharge voucher does not bar arbitration if coercion is alleged: SC (See 'Legal Desk') CCI approves acquisition by Knowledge Realty Trust of entities belonging to Blackstone Group (See 'Corp Brief') PMLA - Prolonged incarceration of accused, where more than 100 witness are yet to be examined would entitle accused for grant of regular bail: HC (See 'Legal Desk') TRAI releases draft manual on rating of properties (See 'Corp Brief') PMLA - definition of value as per Section 2(1)(zb) cannot be read in isolation & must be read along with definition of property and proceeds of crime in order to achieve the aims & objectives of PMLA Act; no definition can be read in isolation: HC (See 'Legal Desk') Union Minister & Goa CM review progress of urban development schemes (See 'Corp Brief') A&C - Objections related to terms of redevelopment agreement raised by members of society can be decided only by appropriate forum having jurisdiction over such issues, and can't be adjudicated u/s 9 of Arbitration Act: HC (See 'Legal Desk') Minister of Ayush launches Weekly Yoga Podcast (See 'Corp Brief') FTDR - Unless specific allegations which discuss role of director in export performance are made, there is no question of finding director personally liable for non-fulfilment of export obligations by company: HC (See 'Legal Desk') Sex Ratio at birth improves from 899 to 913: Govt (See 'Corp Brief') Prevention of Money Laundering Act - Attachment of property can continue if person has not been made an accused : TRIBUNAL (See 'Legal Desk') A Landmark Ruling Reshaping the IBC Framework (See CORP EINSICHT)

Print

Department of Biotechnology, BIRAC host webinar on Biomanufacturing for mRNA Therapeutics

Published: May 17, 2025

By TIOLCorplaws News Service

NEW DELHI, MAY 17, 2025: THE Department of Biotechnology (DBT), Government of India, along with Biotechnology Industry Research Assistance Council (BIRAC) conducted the 14th Webinarunder the 'Webinar Series on Biofoundry and Biomanufacturing Initiative' on 16th May, 2025. The session focused on "Biomanufacturing for mRNA Therapeutics", a vital component under the BioE3 (Bio technology for E conomy, E nvironment & E mployment ) Policy. Approved by the Union Cabinet and released by the Hon'ble Minister of Science & Technology, the BioE3 Policy aims to position India as a global leader in bio-based innovations. It focuses on promoting sustainable biomanufacturing in diverse thematic areas including Precision Therapeutics such as mRNA therapeutics, supporting economic growth while promoting affordable healthcare accessible to the Indian population. This Webinar served as a collaborative forum, bringing together academia, industry experts, start-ups, and researchers to explore the latest developments and emerging opportunities in the field of mRNA therapeutics biomanufacturing.

Dr. Alka Sharma, Senior Adviser/Sc 'H', DBT, highlighted the BioE3 Policy's vision to foster high-performance biomanufacturing by supporting sustainable green growth. She mentioned this approach marks a global shift toward sustainability, fueling a "Bio Revolution" with the potential to reshape economies and societies. She informed that the 14th Webinar in this series focuses on mRNA therapeutics, a key thematic subsector under the policy. She stated that several Indian biotech companies and research institutions are actively involved in developing mRNA-based vaccines and therapeutics.She also highlighted certain challenges plaguing the sector such as product delivery, product stability and import dependence for raw materials.

Dr. Varshneya Singh, Scientist 'D', DBT, provided an insightful overview of the mRNA therapeutics subsector. He emphasized that mRNA-based therapies represent a groundbreaking advancement in biotechnology, with the potential to tackle a broad spectrum of diseases, including cancer, genetic conditions, and infectious diseases. He provided a SWOT analysis of the subsector, identifying its strengths, weaknesses, opportunities, and threats. He concluded by drawing attention to the recently announced Call for Proposals for Precision Biotherapeutics-mRNA Therapeutics, a joint initiative by DBT and BIRAC aimed at fostering discovery, innovation and scale-up in this promising field.

Dr. Raghavan Varadarajan, IISc Bangalorein his talk explored cutting-edge advances in mRNA-LNP vaccine technology, emphasizing its revolutionary role in modern medicine. He talked about the mRNA vaccine design workflow; major advantages of mRNA vaccine modality; key structural elements of mRNA; workflow for LNP preparation, comparative analysis of different mRNA-LNP formulations, different kinds of microfluidic chips used and comparison of different formulation methods.

Dr. Monalisa Chatterji, Sekkei Bio Pvt. Ltd. addressed several pivotal topics, including the current challenges surrounding the limited adoption of biologics and the transformative potential of RNA therapeutics. She highlighted the significant opportunities that exist for unlocking the full promise of these advanced therapies. Dr. Chatterji also emphasized the importance of expanding manufacturing capabilities and capacity, underscoring the critical need for substantial capital investment to drive the maturation and widespread implementation of RNA technologies.

The session concluded with a vibrant Q&A segment moderated by DBT and BIRAC officials. Participants actively engaged with the experts, discussing challenges and opportunities in biomanufacturing and addressing regulatory considerations.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.